Urine-derived stem cell therapy shows promise for reducing surgery complications in boys with hypospadias

NCT ID NCT07495176

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether stem cell exosomes from a boy's own urine could improve healing after surgery for hypospadias, a common birth defect where the urethra opening is not at the tip of the penis. 82 boys with severe hypospadias were split into two groups: one received standard surgery plus the exosome treatment, the other had surgery alone. The goal was to see if the exosomes help rebuild the missing spongy tissue and lower the risk of complications like fistulas or narrowing.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPOSPADIAS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Shanghai Children's Hospital

    Shanghai, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.